Boston settles Guidant spat with JNJ and emerges not too dented

Boston Scientific and Johnson & Johnson have finally buried the hatchet in their longstanding dispute ignited by an intense bidding war for cardiovascular device firm Guidant in late 2005.

More from Archive

More from Medtech Insight